TEL AVIV, Israel, Dec. 20, 2023 (GLOBE NEWSWIRE) -- ImPact Biotech, a clinical-stage biotechnology company focused on developing Padeliporfin Vascular Targeted Photodynamic (VTP) therapy to treat a ...

SINGAPORE: The application portal for vaccinated travel passes (VTP) was temporarily disrupted for several hours on Monday (Nov 22), due to a "concurrent surge" after applications opened for ...

TEL AVIV, Israel, Dec. 04, 2024 (GLOBE NEWSWIRE) -- ImPact Biotech, a clinical-stage biotechnology company focused on developing Padeliporfin vascular targeted photodynamic (VTP) therapy to treat a ...

Here are all the details you might need if you're planning a trip under VTL conditions, including the entry and departure requirements for long-term pass holders, rules for unvaccinated children, and ...

- Complete response (CR) observed in 73% (27/37) of evaluable patients with low-grade upper tract urothelial cancer (UTUC) who completed the Induction Treatment Phase (ITP) - - Padeliporfin VTP ...

- Additional podium presentation to provide updates from long-term evaluation of Padeliporfin VTP in intermediate-risk prostate cancer - TEL AVIV, Israel, April 11, 2025 (GLOBE NEWSWIRE) -- ImPact ...

SINGAPORE: Some travellers from the United Kingdom are facing difficulties entering Singapore under its vaccinated travel lane (VTL) scheme due to certain gaps in the system. The VTL scheme, which ...

Impact Biotech Ltd. has entered into an agreement with Maastricht University to collaborate on research focused on eye treatment to arrest the progression of pathological myopia, also known as myopic ...

OXFORD, United Kingdom, April 17, 2023 (GLOBE NEWSWIRE) – Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company focused on the development of novel T cell immunotherapeutics ...

Arbutus Biopharma Corporation announced promising data from a late-breaker poster presentation at the EASL Congress 2025, revealing that its treatment combining imdusiran, a RNAi therapeutic, with VTP ...